CARDIOVASCULAR EFFECTS OF PHENELZINE AND AMITRIPTYLINE IN DEPRESSED OUTPATIENTS
- 1 January 1982
- journal article
- research article
- Vol. 43 (5) , 8-15
Abstract
Blood pressure and ECG changes were monitored in depressed outpatients treated for 6 wk with amitriptyline 150 mg/day or phenelzine 60 mg/day as part of an ongoing double-blind study. Phenelzine produced significant decreases in blood pressure and a significant increase in orthostatic fall in pressure. Amitriptyline produced little overall change in blood pressure. The degree of monoamine oxidase inhibition in phenelzine-treated patients was significantly correlated with blood pressure. Tricyclic plasma concentrations were related to some blood pressure measures. Reported dizziness/faintness did not correlate with blood pressure changes in either group. Amitriptyline significantly increased heart rate, while phenelzine produced slowing. Amitriptyline was associated with significant prolongation of QRS and QTc but not PR intervals. Phenelzine produced significant shortening of the QTc interval.This publication has 14 references indexed in Scilit:
- Electrocardiogram changes and plasma desipramine levels during treatment of depressionClinical Pharmacology & Therapeutics, 1980
- Electrophysiological effects of imipramine on ovine cardiac Purkinje and ventricular muscle fibers.Circulation Research, 1980
- Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brainNeuropharmacology, 1979
- The effects of desmethylimipramine on the pharmacological actions of alpha methyldopa in manEuropean Journal of Clinical Pharmacology, 1979
- CLINICAL CHARACTERISTICS OF IMIPRAMINE-INDUCED ORTHOSTATIC HYPOTENSIONThe Lancet, 1979
- THE EFFECTS OF CHRONIC REGIMENS OF CLORGYLINE AND PARGYLINE ON MONOAMINE METABOLISM IN THE RAT BRAINJournal of Neurochemistry, 1979
- SENSITIVE METHOD FOR DETERMINATION OF AMITRIPTYLINE AND NORTRIPTYLINE IN HUMAN-PLASMA1976
- Hemodynamic Effects of Pargyline in Hypertensive PatientsCirculation, 1964
- ON THE MECHANISM OF HYPOTENSIVE EFFECTS OF MAO INHIBITORSAnnals of the New York Academy of Sciences, 1963
- The application of a monoamine-oxidase inhibitor, 1-phenyl-2-hydrazinopropane (JB-516), to the treatment of primary hypertensionAmerican Heart Journal, 1959